Biogen
BIIB
BIIB
1,027 hedge funds and large institutions have $34.1B invested in Biogen in 2022 Q4 according to their latest regulatory filings, with 159 funds opening new positions, 323 increasing their positions, 360 reducing their positions, and 96 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more ownership
Funds ownership: →
4% more capital invested
Capital invested by funds: $32.7B → $34.1B (+$1.4B)
10% less repeat investments, than reductions
Existing positions increased: 323 | Existing positions reduced: 360
14% less call options, than puts
Call options by funds: $1.29B | Put options by funds: $1.51B
Holders
1,027
Holding in Top 10
24
Calls
$1.29B
Puts
$1.51B
Top Buyers
| 1 | +$303M | |
| 2 | +$115M | |
| 3 | +$83.1M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$79.5M |
| 5 |
Barclays
London,
United Kingdom
|
+$79.4M |
Top Sellers
| 1 | -$160M | |
| 2 | -$159M | |
| 3 | -$125M | |
| 4 |
Goldman Sachs
New York
|
-$116M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$112M |